34 studies found for:    " May 13, 2009":" June 12, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: GSK1265744;   Drug: Placebo
22 Completed
Has Results
A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir;   Drug: Ritonavir
23 Completed Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment
Conditions: Human Immunodeficiency Virus;   Chronic Hepatitis C
Interventions: Drug: pegylated interferon-alpha (Pegasys);   Drug: ribavirin (COPEGUS)
24 Terminated PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.
Condition: HIV Infections
Intervention: Drug: TMC589337, TMC589354, TMC310911, placebo
25 Completed
Has Results
Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People
Condition: HIV Infection
Intervention:
26 Completed Glutathione and Its Precursors in HIV-Infected Patients
Condition: HIV Infection
Intervention: Dietary Supplement: Glutathione precursors
27 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
28 Completed Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: darunavir/ritonavir;   Drug: lopinavir/ritonavir;   Drug: Midazolam;   Drug: Dextromethorphan;   Drug: Flurbiprofen;   Drug: GSK2248761
29 Completed DDI Study of Etravirine and GSK1265744
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1265744
30 Completed Vitamin D Supplementation and CD4 Count in HIV-Infected Children
Condition: HIV
Interventions: Dietary Supplement: Vitamin D;   Drug: No supplementation
31 Unknown  Examining Hair to Determine Tenofovir Exposure
Condition: HIV
Intervention: Drug: Tenofovir Disoproxil Fumarate
32 Completed A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
Conditions: Postherpetic Neuralgia;   Diabetic Neuropathy;   Complex Regional Pain Syndrome;   Carpal Tunnel Syndrome;   HIV Neuropathy;   Idiopathic Sensory Neuropathy;   Peripheral Neuropathy
Interventions: Drug: Placebo Capsules + Placebo Patch;   Drug: Placebo capsules + Lidoderm®;   Drug: Gabapentin + Placebo;   Drug: Gabapentin + Lidoderm®;   Drug: Gabapentin 300 mg capsules 1800 mg/day + placebo patch;   Drug: Gabapentin 1800 mg/day + Lidoderm patch
33 Completed Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
Conditions: Nonneoplastic Condition;   Precancerous Condition
Interventions: Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: fluorescence activated cell sorting;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: study of high risk factors
34 Completed CyberSenga: Internet-based HIV Prevention in Uganda
Conditions: Sexual Abstinence;   Condom Use
Intervention: Behavioral: CybereSenga

Show previous page of results Previous Page (1-20) Studies Shown (21-34) Next Page
Indicates status has not been verified in more than two years